Loading icon
Categories
Bioinformatics
2
Genetics
10
Art and Literature
3
Tutorials
6
Multiple Sclerosis
5
Omics
2
Trending post
1
How Lipid Metabolism May Shape Multiple Sclerosis Severity: Genetic Evidence from Mendelian Randomization
Genetics
How Lipid Metabolism May Shape Multiple Sclerosis Severity: Genetic Evidence from Mendelian Randomization

25, Aug 2026

2
How Lipid Metabolism May Shape Multiple Sclerosis Severity: Genetic Evidence from Mendelian Randomization
Genetics
Vitamin D and Genetic Susceptibility to Multiple Sclerosis: A Complex Biological Relationship

24, Aug 2026

3
Metabolic Signatures of Multiple Sclerosis: Uncovering Molecular Clues Through Multi-Omic Analysis
Genetics
Metabolic Signatures of Multiple Sclerosis: Uncovering Molecular Clues Through Multi-Omic Analysis

24, Aug 2026

4
Modeling Metabolic Dynamics for Biomarker Discovery in Multiple Sclerosis
Genetics
Modeling Metabolic Dynamics for Biomarker Discovery in Multiple Sclerosis

23, Aug 2026

5
Cerebrospinal Fluid Metabolites and Multiple Sclerosis: Genetic Clues to Disease Risk
Genetics
Cerebrospinal Fluid Metabolites and Multiple Sclerosis: Genetic Clues to Disease Risk

22, Aug 2026

Categories:
Genetics
Unlocking a New Marker in Multiple Sclerosis: How sCD14 Levels Reflect Disease Activity and Treatment Response
Genetics
Unlocking a New Marker in Multiple Sclerosis: How sCD14 Levels Reflect Disease Activity and Treatment Response

08, Jun 2025

Tissue Markers and Personalized Medicine and Treatment Response in Multiple Sclerosis
Genetics
Tissue Markers and Personalized Medicine and Treatment Response in Multiple Sclerosis

09, Jun 2025

Genetics and Drug Response in MS: Why Some Patients Benefit More from First-Line Treatments
Genetics
Genetics and Drug Response in MS: Why Some Patients Benefit More from First-Line Treatments

10, Jun 2025

Plasma GFAP: A Promising Biomarker for Disease Progression and Treatment Response in Secondary Progressive MS
Genetics
Plasma GFAP: A Promising Biomarker for Disease Progression and Treatment Response in Secondary Progressive MS

11, Jun 2025